Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 77
Central Nervous System Drugs 60
Endocrine and Metabolic Disorders Drugs 46
Drug Discovery 32
Infusions and Injectables 25
Musculoskeletal Disorders Drugs 24
Surgical Procedures 20
Pharmaceuticals 17
Biopharmaceuticals 15
Prostate Cancer Drugs 12
Clinical Trials 12
Drug Delivery 11
Liver Cancer Drugs 10
Women's Health 10
Neurology 9
Dermatology 9
Pancreatic Cancer Drugs 9
Lung Cancer Drugs 8
Biotechnology 7
Healthcare Services 7
Immune Disorders Drugs 7
Medical Devices 7
Breast Cancer Drugs 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Thyroid Cancer Drugs 6
Company Reports 5
Ovarian Cancer Drugs 5
Oncology 5
Dermatological Drugs 5
Sexual and Reproductive Health Drugs 5
Urology and Nephrology 4
Brain Cancer Drugs 4
Bladder Cancer Drugs 4
Genomics 4
Enzymes 4
Over the Counter (OTC) Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Colon Cancer Drugs 3
Managed Care 3
Kidney Cancer Drugs 3
Pediatrics 3
Gastroenterology 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Healthcare 2
Diabetes Devices 2
Needles and Syringes 2
Surgical Devices 2
Biosimilars and Biosuperiors 2
Skin Cancer Drugs 2
Nanomedicine 2
Urological Disorders Drugs 2
Pharmaceutical Manufacturing 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Transdermal and Transmucosal Drug Delivery 1
Biomaterials 1
Hematology 1
Hematological Drugs 1
Nuclear Medicine and Radiopharmacology 1
Other Healthcare Facilities 1
Laboratory Equipment 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

419 Results (Page 12 of 21)
- Relevance
  Sort by

Cervical Dystonia Therapeutics Market 2021-2025

 Report
January 2022
120 Pages
Global

From

€2469EUR$2,500USD£2,058GBP

Tie-2 modulators - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1037EUR$1,050USD£864GBP

€1482EUR$1,500USD£1,235GBP

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

 Report
August 2022
58 Pages
Asia Pacific

€9934EUR$10,410USD£8,000GBP

Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€864EUR$875USD£720GBP

€1235EUR$1,250USD£1,029GBP

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
871 Pages
Global

From

€2469EUR$2,500USD£2,058GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Growth Hormone Antagonist - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€864EUR$875USD£720GBP

€1235EUR$1,250USD£1,029GBP

Dystonia Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration, By Type, By Regional Outlook and Forecast, 2022 - 2028

 Report
February 2023
200 Pages
Global

From

€3556EUR$3,600USD£2,964GBP

D1 Agonist - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€864EUR$875USD£720GBP

€1235EUR$1,250USD£1,029GBP

OTC Consumer Health Products Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
November 2023
118 Pages
Global

From

€3500EUR$3,796USD£3,019GBP

Oligodendroglioma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
September 2024
96 Pages
Global

From

€3500EUR$3,796USD£3,019GBP

Pituitary ACTH Hypersecretion Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
96 Pages
Global

From

€3500EUR$3,796USD£3,019GBP

Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
3237 Pages
Global

From

€2469EUR$2,500USD£2,058GBP

Acromegaly Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

 Report
January 2024
75 Pages
Global

From

€3500EUR$3,796USD£3,019GBP

Acromegaly and Gigantism Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
December 2023
73 Pages
Global

From

€3500EUR$3,796USD£3,019GBP

Adrenocortical Carcinoma - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€864EUR$875USD£720GBP

€1235EUR$1,250USD£1,029GBP

Acromegaly Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
105 Pages
Global

From

€4692EUR$4,750USD£3,910GBP

Human Somatotropin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
October 2023
105 Pages
Global

From

€3500EUR$3,796USD£3,019GBP

Human Growth Hormone Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
October 2023
112 Pages
Global

From

€3500EUR$3,796USD£3,019GBP

Botulinum Toxin Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
October 2022
215 Pages
Global

From

€3526EUR$3,570USD£2,939GBP

Prolactin Receptor Antagonist - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€864EUR$875USD£720GBP

€1235EUR$1,250USD£1,029GBP

419 Results (Page 12 of 21)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.